RSV

All articles by RSV

Making RSV splash, AstraZeneca buys Icosavax in deal worth up to $1.1B
Making RSV splash, AstraZeneca buys Icosavax in deal worth up to $1.1B
Lecia Bushak
December 12, 2023
11:48 am

AstraZeneca will bring Icosavax’s lead candidate, a combination RSV and hMPV vaccine called IVX-A12, into its late-stage pipeline.

A new RSV shot could help protect babies this winter — if they can get it in time
A new RSV shot could help protect babies this winter — if they can get it in time
Amelia Templeton, Oregon Public Broadcasting for KFF Health News
November 10, 2023
10:00 am

RSV is the leading reason babies under 12 months old end up in the hospital, and an estimated 100-300 kids under age 5 die from it in the U.S. every year.

FDA approves Pfizer’s RSV vaccine for pregnant people to protect infants
FDA approves Pfizer’s RSV vaccine for pregnant people to protect infants
Jack O'Brien
August 22, 2023
10:58 am

Abrysvo, Pfizer’s RSV vaccine, was approved by the FDA earlier this year to prevent the disease in people over the age of 60.

FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for children
FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for children
Jack O'Brien
July 17, 2023
3:31 pm

AstraZeneca and Sanofi stated that a single dose demonstrated “high and consistent efficacy” against RSV LRTD and that they plan to make Beyfortus available in the U.S. by the fall.

Pfizer joins GSK with FDA greenlight for RSV vaccine
Pfizer joins GSK with FDA greenlight for RSV vaccine
Jack O'Brien
June 1, 2023
11:10 am

Pending results of a CDC adcomm meeting, Pfizer said it anticipates vaccine supply availability in Q3 2023 ahead of the start of the 2023/24 RSV season this fall.

Sanofi’s RSV vaccine reduces infant hospitalizations by 83%
Sanofi’s RSV vaccine reduces infant hospitalizations by 83%
Jack O'Brien
May 12, 2023
10:01 am

A target action date for the FDA is expected in Q3 2023 and if greenlit, Sanofi’s nirsevimab would be the first broadly-approved RSV vaccine for children.

Cut Short by RSV: GSK’s compelling ad ties into recent FDA approval
Cut Short by RSV: GSK’s compelling ad ties into recent FDA approval
Jack O'Brien
May 8, 2023
12:17 pm

Two days before the FDA approved GSK’s vaccine, NBA Hall of Famer Earvin “Magic” Johnson again provided his starpower and healthcare advocacy for a 30-second spot supporting Cut Short by RSV.

GSK nabs first FDA approval for RSV vaccine
GSK nabs first FDA approval for RSV vaccine
Jack O'Brien
May 3, 2023
2:00 pm

In light of the approval, GSK said it intends to launch Arexy prior to the start of the 2023/24 RSV season this fall.

Pfizer heralds promising RSV vaccine data ahead of showdown with GSK, Moderna
Pfizer heralds promising RSV vaccine data ahead of showdown with GSK, Moderna
Jack O'Brien
April 6, 2023
1:57 pm

The data publication comes just over a month after the FDA’s adcomm voted in support of Pfizer’s RSVpreF vaccine.

Magic Johnson takes the court to sideline RSV in GSK’s latest campaign
Magic Johnson takes the court to sideline RSV in GSK’s latest campaign
Jack O'Brien
March 16, 2023
10:05 am

Johnson is starring in a 45-second ad centering around the risks presented by RSV in older people and those with underlying conditions.

  • From Our Partners